Immunization against Mpox infection is coercive: A timely call

Authors

DOI:

https://doi.org/10.3329/bjid.v12i1.76624

Keywords:

Mpox, Mpox vaccine, Immunization, Viral infection

Abstract

Mpox or monkeypox is a viral zoonotic disease caused by the monkeypox virus (MPXV). Recently, Mpox has been on the rise, and its multi-country spread has alarmed health officials throughout the world. Vaccination is essential for the prevention and management of mpox cases because there is currently no particular cure against the mpox virus. The current mpox epidemic calls for urgent action in the form of immunization. However, the smallpox vaccine and a newer vaccine named Modified Vaccinia Ankara (MVA) vaccine are effective against the disease. JYNNEOS vaccine is approved to be used in mpox cases. However, its efficacy and wide-scale production are still a matter of concern. The ACAM2000 vaccine, which also protects against both smallpox and mpox though it has severe adverse effects. Only an effective vaccination can drastically lower mpox infection and death rates. Safe and effective vaccines, along with their equitable distribution, are vital for global health. This article explores the importance of addressing this challenge.

Bangladesh Journal of Infectious Diseases, June 2025;12(1):185-188

Downloads

Download data is not yet available.
Abstract
49
PDF
17

Downloads

Published

2025-10-28

How to Cite

Ahmed, I., Ahamed, R., Bari, L. F., Shanto, M. Y., & Tahsin, M. R. (2025). Immunization against Mpox infection is coercive: A timely call. Bangladesh Journal of Infectious Diseases, 12(1), 185–188. https://doi.org/10.3329/bjid.v12i1.76624

Issue

Vol. 12 No. 1 (2025)

Section

Perspective

License

Copyright (c) 2025 Iftekhar Ahmed, Rayhan Ahamed, Lazima Faiah Bari, Md. Yusuf Shanto1, Md. Rafat Tahsin

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright

Copyright on any research article in the Bangladesh Journal of Infectious Diseases is retained by the author(s).

The authors grant the Bangladesh Infection Research Association a license to publish the article and identify itself as the original publisher.

Articles in the Bangladesh Journal of Infectious Diseases are Open Access articles published under the Creative Commons CC BY-NC License (https://creativecommons.org/licenses/by-nc/4.0/)

This license permits use, distribution and reproduction in any medium, provided the original work is properly cited, and it is not used for commercial purposes.